Case Report on Management of Pregnancy in a Patient with Small Muscular Ventricular Septal Defect

Introduction: Maternal morbidity and mortality during pregnancy is significantly associated with hypertensive disorders. Patient history: A 33 years old female was admitted in AVBRH with chief complaint of breathing difficulty with G2P1A1L1 having 30 weeks of gestational age with previous LSCS and conception with small muscular ventricular septal defect, normal function and rhythm for the period of gestation. Obstetric history: Patient had bad obstetric history of 1 induced abortion. Clinical findings: The patient had undergone various investigations like blood tests, USG, Physical examination and antenatal per abdominal examination. Medical Management: Patient was treated with calcium supplement and iron supplement. Nursing management: Administered fluid replacement i.e. DNS and RL, Foetal monitoring, hourly vital sign monitoring. Conclusion: Timely treatment of Ventricular Small Muscular Septal Defect and Management in pregnancy improved the outcome of pregnancy.

Cyanosis in a patient after Fontan palliation due to unrecognised hepatic vein to coronary sinus communication

A 6-year-old male with heterotaxia, abnormal systemic and pulmonary venous drainage, and a history of Fontan completion presented with desaturations and was found by cardiac catheterisation to have a hepatic vein to coronary sinus connection. This was successfully occluded using an Amplatzer Muscular Ventricular Septal Defect Occluder.

Levoatriocardinal Vein With Multiple Ventricular Septal Defects and Without Left-Sided Valvular Atresia

Levoatriocardinal vein without left-sided valvular atresia is rare. We hereby present an image of the levoatriocardinal vein in a patient with multiple muscular ventricular septal defect with small atrial septal defect and mitral regurgitation.

Hybrid perventricular muscular ventricular septal defect closure using the new multi-functional occluder

The hybrid perventricular approach for the closure of trabecular ventricular septal defects is an attractive treatment modality for small children. Worldwide experience has shown that procedure success is influenced by the defect anatomical accessibility, operators’ expertise, and device technical features. In May 2018, a new promising device, the KONAR-Multi-functional™ ventricular septal defect occluder (Lifetech, Shenzhen, China), obtained CE-marking for septal defect transcatheter closure after the first-in-man implantation in 2013. Herein, this is the first report of successful perventricular closure of ventricular septal defect using this new device in a child with significant co-morbidities.

4-month-old boy coinfected with COVID-19 and adenovirus

A 4-month-old boy with a history of muscular ventricular septal defect and atopic dermatitis presented with decreased oral intake, loose stools, stuffy nose, mild cough and diaphoresis. The patient had an in-home exposure to COVID-19. The initial respiratory pathogen panel was positive for adenovirus, consistent with his symptoms. The following day, the COVID-19 PCR was also positive. The patient was treated with supportive care, isolation precautions were implemented and the patient was discharged on day 4. This case demonstrates the importance of testing for COVID-19 even if a patient tests positive for another virus due to the possibility of coinfection, especially in children, in order to limit spread of COVID-19 to others.

Spontaneous closure of muscular ventricular septal defect by growth of right ventricular muscle bundles: a rare mechanism

We present a case of an 18-year-old male with large anterior muscular ventricular septal defect. Assessment by echocardiography showed that the defect has completely closed by the growth of muscle bundles that formed a pouch-like structure on the right ventricular side. This unusual mechanism of closure has been reported in one prior case report. In our report, we present images obtained by three-dimensional echocardiography.